Discussion forum for Pharma Quality events, Regulatory Actions

Warning letters, 483s, Recalls, Import Alerts, Audit observations

USFDA Publishes 200+ CRLs: Gives Insight

USFDA has published over 200+ redacted Complete Response Letters (CRLs) issued to drug applicants. The

Qvents
July 14, 2025

Biocon’s Biosimilar insulin Aspart rec

In a company announcement, Biocon informed that it has received a CR (Complete response) letter

Qvents
October 17, 2023